Rucaparib 200mg and 300mg tablets are advanced prescription medicines used in the treatment of specific types of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. As a targeted cancer therapy, Rucaparib belongs to the class of medicines known as PARP (Poly ADP-Ribose Polymerase) inhibitors.
Cordium Pharmaceuticals Pvt Ltd is committed to supplying high-quality oncology medicines globally, serving healthcare providers, hospitals, distributors, and pharmaceutical importers across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Rucaparib?
Rucaparib is an oral anti-cancer medication designed to target cancer cells with defective DNA repair mechanisms, particularly those with BRCA1 and BRCA2 gene mutations.
It works by blocking PARP enzymes, preventing cancer cells from repairing damaged DNA, ultimately causing cancer cell death while minimizing damage to healthy cells.
Common Indications
Rucaparib is prescribed for:
Recurrent ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer
BRCA-positive ovarian cancer
Maintenance treatment after chemotherapy
Advanced ovarian cancer management
How Does Rucaparib Work?
Rucaparib inhibits PARP enzymes responsible for repairing damaged DNA inside cells.
Mechanism of Action:
Blocks PARP enzyme activity
Prevents DNA repair in cancer cells
Causes accumulation of DNA damage
Triggers cancer cell death
Helps delay disease progression
This precision medicine approach has transformed ovarian cancer treatment worldwide.
Benefits of Rucaparib 200mg/300mg Tablets
Key Advantages:
✅ Targeted cancer therapy
✅ Oral administration (no hospital infusion required)
✅ Delays cancer progression
✅ Supports long-term disease management
✅ Effective in BRCA-mutated cancers
✅ Improves progression-free survival
✅ Convenient home-based treatment
Recommended Dosage
Always follow your oncologist's instructions.
Typical adult dosage:
Rucaparib 600 mg orally twice daily
Tablets available in:
Rucaparib 200mg
Rucaparib 300mg
Administration Guidelines
Take with or without food.
Swallow tablets whole.
Take doses approximately 12 hours apart.
Do not crush, chew, or split tablets.
Continue treatment until disease progression or unacceptable toxicity.
Common Side Effects of Rucaparib
Patients may experience:
Nausea
Vomiting
Fatigue
Anemia
Loss of appetite
Diarrhea
Constipation
Increased liver enzymes
Taste changes
Abdominal pain
Dizziness
Seek immediate medical attention for severe or unusual symptoms.
Important Safety Precautions
Before starting Rucaparib:
Inform your doctor about all medications.
Discuss any liver or kidney conditions.
Avoid pregnancy during treatment.
Use effective contraception.
Avoid breastfeeding during treatment.
Undergo regular blood tests.
Attend scheduled oncology follow-ups.
This medicine must only be used under the supervision of a qualified oncologist.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter specializing in high-quality oncology medicines.
Our Strengths:
✔ WHO-GMP compliant manufacturing partners
✔ Global pharmaceutical exports
✔ Regulatory documentation support
✔ Reliable supply chain management
✔ Competitive pricing
✔ Timely international delivery
✔ Bulk order capabilities
✔ Dedicated customer support
Global Export Markets We Serve
Cordium Pharmaceuticals Pvt Ltd actively supplies oncology products to:
🌍 East Africa
Kenya
Nigeria
Ghana
South Africa
🌏 Asia
Philippines
Vietnam
Uzbekistan
Kazakhstan
🌍 Middle East
UAE
Saudi Arabia
🌎 Western Markets
USA
UK
We collaborate with:
Pharmaceutical distributors
Oncology hospitals
Government tenders
Cancer treatment centers
Importers and wholesalers
Frequently Asked Questions (FAQs)
Is Rucaparib chemotherapy?
No. Rucaparib is a targeted therapy and belongs to the PARP inhibitor class of anti-cancer medicines.
Who can take Rucaparib?
Patients diagnosed with specific ovarian, fallopian tube, or primary peritoneal cancers, especially those with BRCA mutations, under oncologist supervision.
Is genetic testing required?
Yes, doctors may recommend BRCA mutation testing before starting treatment.
Can Rucaparib cure ovarian cancer?
Rucaparib is not considered a cure but can significantly help manage disease progression and improve outcomes in eligible patients.
Contact Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is your reliable global partner for quality oncology medicines and international pharmaceutical exports.
Serving: 🇰🇪 Kenya | 🇳🇬 Nigeria | 🇬🇭 Ghana | 🇵🇭 Philippines | 🇻🇳 Vietnam | 🇦🇪 UAE | 🇸🇦 Saudi Arabia | 🇺🇿 Uzbekistan | 🇰🇿 Kazakhstan | 🇺🇸 USA | 🇬🇧 UK | 🇿🇦 South Africa
